RGEN
Price:
$165.76
Market Cap:
$9.33B
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test k...[Read more]
Industry
Medical - Instruments & Supplies
IPO Date
1986-04-29
Stock Exchange
NASDAQ
Ticker
RGEN
According to Repligen Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 9.27B. This represents a change of 25.52% compared to the average of 7.39B of the last 4 quarters.
The mean historical Enterprise Value of Repligen Corporation over the last ten years is 6.08B. The current 9.27B Enterprise Value has changed 15.15% with respect to the historical average. Over the past ten years (40 quarters), RGEN's Enterprise Value was at its highest in in the September 2021 quarter at 15.59B. The Enterprise Value was at its lowest in in the March 2016 quarter at 832.51M.
Average
6.08B
Median
6.09B
Minimum
856.82M
Maximum
14.33B
Discovering the peaks and valleys of Repligen Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 128.90%
Maximum Annual Enterprise Value = 14.33B
Minimum Annual Increase = -35.19%
Minimum Annual Enterprise Value = 856.82M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 7.98B | -20.03% |
| 2023 | 9.98B | 7.42% |
| 2022 | 9.29B | -35.19% |
| 2021 | 14.33B | 48.85% |
| 2020 | 9.63B | 128.90% |
| 2019 | 4.21B | 89.67% |
| 2018 | 2.22B | 68.97% |
| 2017 | 1.31B | 32.83% |
| 2016 | 988.21M | 15.33% |
| 2015 | 856.82M | 47.36% |
The current Enterprise Value of Repligen Corporation (RGEN) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
9.08B
5-year avg
10.24B
10-year avg
6.08B
Repligen Corporation’s Enterprise Value is less than Avantor, Inc. (11.21B), greater than Masimo Corporation (7.93B), less than Baxter International Inc. (17.48B), greater than AptarGroup, Inc. (8.69B), less than Bio-Rad Laboratories, Inc. (9.63B), less than DaVita Inc. (22.45B), less than Charles River Laboratories International, Inc. (11.66B), less than Globus Medical, Inc. (11.62B), greater than Stevanato Group S.p.A. (5.71B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 11.21B | $7.60B | |
| 7.93B | $7.68B | |
| 17.48B | $9.50B | |
| 8.69B | $8.07B | |
| 9.63B | $8.63B | |
| 22.45B | $8.28B | |
| 11.66B | $9.06B | |
| 11.62B | $11.88B | |
| 5.71B | $6.26B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Repligen Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Repligen Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Repligen Corporation's Enterprise Value?
What is the highest Enterprise Value for Repligen Corporation (RGEN)?
What is the 3-year average Enterprise Value for Repligen Corporation (RGEN)?
What is the 5-year average Enterprise Value for Repligen Corporation (RGEN)?
How does the current Enterprise Value for Repligen Corporation (RGEN) compare to its historical average?